HIV Prevention Program for HIV Testing
(P3 Trial)
Trial Summary
What is the purpose of this trial?
The major goal of this study is to evaluate a multi-component, multilevel HIV prevention intervention that targets theoretically-informed and empirically-identified barriers to and facilitators of both HIV testing and PEP/PrEP uptake by combining existing evidence-based and novel evidence-informed components and integrating them into a community-based organization's (CBO) standard of care (SOC) PEP/PrEP navigation program. The evaluation will apply use a 2x2 factorial design to randomize and follow for 18 months 480 PrEP-eligible Black MSM (aged 18-65) living in the NYC area to one of four combinations of interventions. The impact of the social/media campaign, delivered to both geographic (print media) and Black MSM communities (social media) and launched midway through recruitment, will be assessed through assessment of timing and length of exposure as covariates in analysis.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, you cannot be currently on PEP or PrEP to participate.
What data supports the effectiveness of the treatment DIY (Do It Yourself) for HIV prevention?
Research shows that HIV self-testing (a form of DIY testing) increases testing frequency among high-risk groups, such as gay and bisexual men, and helps connect them to prevention services. Studies found that those using self-testing kits were more likely to test regularly and receive counseling and prevention supplies compared to those who did not use self-testing.12345
Is HIV self-testing generally safe for humans?
How does the HIV Prevention Program using DIY, SOC, and TRUST differ from other HIV testing treatments?
The HIV Prevention Program is unique because it includes HIV self-testing (HIVST), which allows individuals to perform and interpret their own HIV tests at home. This approach increases access to testing, especially for those who might not visit a clinic, and is part of a global effort to improve HIV testing coverage.510111213
Eligibility Criteria
This trial is for African-American/Black gay, bisexual, and same-gender loving men aged 18-65 living in the NYC area. They must be eligible for PrEP (HIV prevention medication) but not currently using it. The study excludes individuals who don't meet these criteria or can't commit to an 18-month follow-up.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive a multi-component, multilevel HIV prevention intervention including TRUST, DIY, and a social/print media campaign
Follow-up
Participants are monitored for HIV testing and PrEP/PEP uptake and adherence
Treatment Details
Interventions
- DIY (Do It Yourself)
- SOC
- TRUST
Find a Clinic Near You
Who Is Running the Clinical Trial?
Columbia University
Lead Sponsor
National Institute of Mental Health (NIMH)
Collaborator